Imagine a world where blindness can be reversed with an implant smaller than a grain of rice. This isn’t science fiction—it’s the reality.
In a surprising and significant move, 180 Life Sciences (Nasdaq: ATNF), a prominent biotechnology company also known by the intriguing moniker “ETHZilla,” recently.
The convergence of traditional finance and the dynamic world of digital assets is accelerating, exemplified by a truly groundbreaking announcement. 180 Life Sciences,.